Group One Trading, L.P. Virios Therapeutics, Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.18 - $0.58 $1,226 - $3,952	-6,814 Reduced 84.01%	1,297 $0
Q1 2024 May 10, 2024	SELL	$0.31 - $0.84 $1,820 - $4,931	-5,871 Reduced 41.99%	8,111 $3,000
Q4 2023 Feb 14, 2024	BUY	$0.46 - $0.9 $1,150 - $2,250	2,500 Added 21.77%	13,982 $7,000
Q3 2023 Nov 09, 2023	SELL	$0.86 - $2.42 $4,412 - $12,417	-5,131 Reduced 30.89%	11,482 $10,000
Q2 2023 Aug 09, 2023	BUY	$0.35 - $1.94 $785 - $4,355	2,245 Added 15.63%	16,613 $22,000
Q1 2023 May 12, 2023	SELL	$0.24 - $0.44 $1,356 - $2,487	-5,654 Reduced 28.24%	14,368 $5,000
Q4 2022 Feb 09, 2023	BUY	$0.24 - $0.39 $2,040 - $3,315	8,500 Added 73.77%	20,022 $4,000
Q3 2022 Nov 09, 2022	BUY	$0.37 - $8.77 $4,263 - $101,047	11,522 New	11,522 $4,000

36.1K

Ticker VIRI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,330,400
Market Cap $81.4M
Description
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.